These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11411125)

  • 21. [Prostacyclin derivatives].
    Nagaya N
    Nihon Rinsho; 2008 Nov; 66(11):2145-50. PubMed ID: 19051734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.
    Higenbottam TW; Butt AY; Dinh-Xaun AT; Takao M; Cremona G; Akamine S
    Heart; 1998 Feb; 79(2):175-9. PubMed ID: 9538312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV; Genthner DE; Panella MM; Rich S
    N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.
    O'Connell C; Amar D; Boucly A; Savale L; Jaïs X; Chaumais MC; Montani D; Humbert M; Simonneau G; Sitbon O
    Drug Saf; 2016 Apr; 39(4):287-94. PubMed ID: 26748508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery.
    Bildirici I; Shumway JB
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1102-5. PubMed ID: 15121623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of pulmonary hypertension with aerosolized iloprost.
    Machherndl S; Kneussl M; Baumgartner H; Schneider B; Petkov V; Schenk P; Lang IM
    Eur Respir J; 2001 Jan; 17(1):8-13. PubMed ID: 11307761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
    Petkov V; Ziesche R; Mosgoeller W; Schenk P; Vonbank K; Stiebellehner L; Raderer M; Brunner C; Kneussl M; Block LH
    Thorax; 2001 Sep; 56(9):734-6. PubMed ID: 11514696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
    Andreassen AK; Madsen S; Kjekshus J; Simonsen S
    Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin).
    Klings ES; Hill NS; Ieong MH; Simms RW; Korn JH; Farber HW
    Arthritis Rheum; 1999 Dec; 42(12):2638-45. PubMed ID: 10616012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.
    McLaughlin VV; Palevsky HI
    Clin Chest Med; 2013 Dec; 34(4):825-40. PubMed ID: 24267307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
    Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
    Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Continuous intravenous prostacyclin therapy].
    Miyaji K; Matsubara H
    Nihon Rinsho; 2008 Nov; 66(11):2139-44. PubMed ID: 19051733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term treatment of primary pulmonary hypertension with inhaled iloprost].
    Hoeper MM; Schwarze M; Ehlerding S; Adler-Schuermeyer A; Spiekerkoetter E; Niedermeyer J; Hamm M; Fabel H
    Pneumologie; 2001 Jan; 55(1):38-43. PubMed ID: 11236355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
    Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit.
    Haché M; Denault AY; Bélisle S; Couture P; Babin D; Tétrault F; Guimond JG
    Can J Anaesth; 2001 Oct; 48(9):924-9. PubMed ID: 11606352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostacyclin in the intensive care setting.
    Ivy DD
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S41-5. PubMed ID: 20216163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
    Kramer MR; Fucks S; Simon Z; Berkman N
    Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalation of repurposed drugs to treat pulmonary hypertension.
    Gessler T
    Adv Drug Deliv Rev; 2018 Aug; 133():34-44. PubMed ID: 29886070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.
    Ferrantino M; White RJ
    Expert Opin Pharmacother; 2011 Nov; 12(16):2583-93. PubMed ID: 21988216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.